Related Experiment Video
Updated: Apr 28, 2026

Exosomal miRNA Analysis in Non-small Cell Lung Cancer NSCLC Patients' Plasma Through qPCR: A Feasible Liquid Biopsy Tool
Published on: May 27, 2016
Small nucleolar RNA signatures of lung tumor-initiating cells
Kaiissar Mannoor, Jun Shen, Jipei Liao
1Departments of Pathology, University of Maryland School of Medicine, Baltimore, MD, USA. fjiang@som.umaryland.edu.
Background:
Non-small cell lung cancer (NSCLC) is the number one cancer killer. Tumor-initiating cells (TICs) are responsible for tumor progression and recurrence. Emerging evidences suggest that small nucleolar RNAs (snoRNAs) play malfunctioning roles in lung tumorigenesis. This study aims to determine if snoRNAs have important function in lung TICs by: 1) profiling and comparing snoRNA expression patterns in lung ALDH1+/- cells of 28 primary NSCLC tissues to identify new signatures of TICs; 2) determining prognostic significance of the snoRNA signatures by analyzing the expression in 82 NSCLC tissues with different stages and histological types using quantitative PCR; 3) functionally investigating if the snoRNAs contribute to stemness of lung TICs using in vitro and in vivo assays.
Results:
Twenty-two snoRNAs were identified whose changes were specific to the TICs. The expression of two snoRNAs (snoRA3 and snoRA42) was inversely associated with survival of NSCLC patients (P = 0.002, p = 0.001, respectively). Functional analysis indicated that snoRA42 was upregulated in CD133+ cells isolated from NSCLC cell lines compared with the CD133- counterparts. snoRA42 knockdown reduced the proliferation and self-renewal of TICs in vitro. However, ectopic expression of snoRA42 in non-TICs enhanced the potentials of cell proliferation and self-renewal. snoRA42 expression was associated with expression of stem cell-core transcription factors in lung TICs. Blocking snoRA42 expression in TIC xenografts decreased tumorigenesis in mice.
Conclusions:
The snoRNA signatures of lung TICs provide potential biomarkers for predicting outcome of NSCLC. snoRA42 is one of the important snoRNAs in regulating features of lung TICs, and thus contributes to lung tumorigenesis.
Insights
Small nucleolar RNAs (snoRNAs) may drive non-small cell lung cancer (NSCLC) progression. Specific snoRNAs, like snoRA42, regulate tumor-initiating cells (TICs) and could serve as biomarkers for predicting patient outcomes.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Non-small cell lung cancer (NSCLC) remains a leading cause of cancer mortality.
- Tumor-initiating cells (TICs) are critical drivers of NSCLC progression and recurrence.
- Small nucleolar RNAs (snoRNAs) are implicated in lung tumorigenesis.
Purpose of the Study:
- To identify novel snoRNA signatures specific to lung TICs.
- To evaluate the prognostic significance of these snoRNA signatures in NSCLC patients.
- To functionally investigate the role of snoRNAs in regulating lung TIC stemness and tumorigenesis.
Main Methods:
- Profiling and comparison of snoRNA expression in lung ALDH1+/- cells from NSCLC tissues.
- Quantitative PCR analysis of snoRNA expression in 82 NSCLC tissues for prognostic evaluation.
- In vitro and in vivo assays to assess the functional impact of snoRNAs on TIC properties.
Main Results:
- Twenty-two snoRNAs were identified as specific to TICs.
- Expression of snoRA3 and snoRA42 inversely correlated with NSCLC patient survival.
- snoRA42 knockdown impaired TIC proliferation and self-renewal, while its ectopic expression enhanced these traits; snoRA42 also influenced stem cell transcription factors and reduced tumorigenesis in vivo.
Conclusions:
- Identified snoRNA signatures may serve as potential biomarkers for predicting NSCLC outcomes.
- snoRA42 plays a crucial role in regulating lung TIC characteristics and contributes to lung tumorigenesis.
Related Concept Videos
lncRNA - Long Non-coding RNAs
The Nucleolus
Non-LTR Retrotransposons

